Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zynex (ZYXI)
NASDAQ:ZYXI
Holding ZYXI?
Track your performance easily
ZYXI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.88 - $13.77
Previous Close$9.44
Volume83.69K
Average Volume (3M)128.65K
Market Cap
$299.96M
Enterprise Value$342.53M
Total Cash (Recent Filing)$32.86M
Total Debt (Recent Filing)$75.43M
Price to Earnings (P/E)41.8
Beta1.17
Next Earnings
Jul 25, 2024EPS Estimate
$0.08Last Dividend Ex-Date
Jan 05, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding31,775,183
10 Day Avg. Volume122,902
30 Day Avg. Volume128,652
Standard Deviation0.17
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)8.65
Price to Sales (P/S)1.55
Price to Cash Flow (P/CF)34.60
P/FCF Ratio31.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.82
Enterprise Value/Gross Profit2.35
Enterprise Value/Ebitda32.38
Forecast
1Y Price Target
$18.00Price Target Upside91.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Zynex News
Bulls Say, Bears Say
Bulls Say
Financial OutlookManagement expects a significant increase in revenue and earnings per share in the coming quarter.
GrowthOrders grew 23% year-over-year, continuing a trend of increasing demand.
Stock BuybackThe company's strong cash reserves are being used to fund a share repurchase program, indicating confidence in the stock's value.
Bears Say
Business RisksRisks include slower-than-anticipated revenue growth, inability to secure regulatory clearance for medical devices.
EarningsTopline miss in 1Q24; full-year 2024 guidance unchanged.
Financial PerformanceFor 4Q23, total revenue was $47.3M, representing 3% year-on-year decline and missing projections.
---
Ownership Overview
0.86% Insiders
9.65% Mutual Funds
6.09% Other Institutional Investors
83.40% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZYXI FAQ
What was Zynex’s price range in the past 12 months?
Zynex lowest stock price was $6.88 and its highest was $13.77 in the past 12 months.
What is Zynex’s market cap?
Currently, no data Available
When is Zynex’s upcoming earnings report date?
Zynex’s upcoming earnings report date is Jul 25, 2024 which is 150 days ago.
How were Zynex’s earnings last quarter?
Zynex released its earnings results on Apr 30, 2024. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.033 by -$0.033.
Is Zynex overvalued?
According to Wall Street analysts Zynex’s price is currently Undervalued.
Does Zynex pay dividends?
Zynex pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Zynex dividends here
What is Zynex’s EPS estimate?
Zynex’s EPS estimate is $0.08.
How many shares outstanding does Zynex have?
Zynex has 31,775,183 shares outstanding.
What happened to Zynex’s price movement after its last earnings report?
Zynex reported an EPS of $0 in its last earnings report, missing expectations of $0.033. Following the earnings report the stock price went up 7.293%.
Which hedge fund is a major shareholder of Zynex?
Among the largest hedge funds holding Zynex’s share is Hotchkis & Wiley Capital Management LLC. It holds Zynex’s shares valued at 5M.
---
Zynex Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.00 (91.49% Upside)
$18.00 (91.49% Upside)
Blogger Sentiment
Bullish
ZYXI Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 598.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.39%
12-Months-Change
Fundamentals
Return on Equity
16.75%
Trailing 12-Months
Asset Growth
13.66%
Trailing 12-Months
Company Description
Zynex
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.
---
ZYXI Earnings Call
Q1 2024
0:00 / 0:00
---
ZYXI Stock 12 Month Forecast
Average Price Target
$18.00
▲(91.49% Upside)
Technical Analysis
Best Analysts Covering ZYXI
1 Year
1 Year Success Rate
7/14 ratings generated profit
1 Year Average Return
+12.00%
reiterated a buy rating 8 months ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +12.00% per trade.
---